Inventor · disambiguated record
Patrick Andre
Also filed as: ANDRE PATRICK · ANDRE PATRICK D · ANDRE PATRICK DEAN
23 granted patents·29 pending applications·526 citations·filing 1995–2025
96Inventor score
Files withACCELERON PHARMA INC12PORTOLA PHARM INC10PLIANT THERAPEUTICS INC5ANDRE PATRICK3MILLENNIUM PHARM INC3
Top patents by PatentIndex Score
52 records- 0197US8153590B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2008·Granted Apr 10, 2012·56 cites·18 claims
- 0295US10604520B2N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·20 cites·52 claims
- 0395US9388401B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Granted Jul 12, 2016·18 cites·19 claims
- 0495US9062298B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Jun 23, 2015·21 cites·18 claims
- 0595US8889129B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Nov 18, 2014·18 cites·22 claims
- 0695US8455441B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2012·Granted Jun 4, 2013·27 cites·18 claims
- 0792US11673887B2N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jun 13, 2023·3 cites·68 claims
- 0891US10675335B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Granted Jun 9, 2020·3 cites·3 claims
- 0990US7358091B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·23 cites·14 claims
- 1089US6682475B2Tension indicator for cardiac support device and method thereforeACORN CARDIOVASCULAR INC·Filed 2002·Granted Jan 27, 2004·195 cites·44 claims
- 1188US2024082367A1Antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 1286US11839646B2Antidotes for factor Xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2020·Granted Dec 12, 2023·1 cites·12 claims
- 1384US7785891B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2008·Granted Aug 31, 2010·10 cites·11 claims
- 1481US6149355ABall nose end mill and a cutting insert for the ball nose end millSAFETY SA·Filed 1997·Granted Nov 21, 2000·48 cites·7 claims
- 1580US7387777B2Methods of treating hemophilia or von willebrand disease with p-selectinBLOOD RES CENTER·Filed 2004·Granted Jun 17, 2008·17 cites·7 claims
- 1679US2025082722A1Actrii proteins for the treatment of pulmonary arterial hypertension (pah)ACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 1778US8455440B2Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitorSINHA UMA·Filed 2011·Granted Jun 4, 2013·3 cites·24 claims
- 1877US2023365556A1N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1975US2025026819A1Methods of treatment comprising antibodies binding to alpha7beta1 integrin antibodiesPLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2071US8057815B2Methods of treatment with Syk inhibitorsANDRE PATRICK·Filed 2005·Granted Nov 15, 2011·2 cites·13 claims
- 2171US7271152B2Compounds and methods for the modulation of CD154CBR INST FOR BIOMEDICAL RES·Filed 2002·Granted Sep 18, 2007·11 cites·44 claims
- 2269US8946219B2Combination therapy with a compound acting as a platelet ADP receptor inhibitorCONLEY PAMELA B·Filed 2010·Granted Feb 3, 2015·2 cites·13 claims
- 2369US2025249070A1Actrii proteins for the treatment of pulmonary arterial hypertension (pah)ACCELERON PHARMA INC·Filed 2025·Application pending·0 cites
- 2466US2023226146A1Actrii proteins for the treatment of pulmonary arterial hypertension (pah)ACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 2565US12134642B2Antibodies binding to α7β1 integrin antibodies and compositions thereofPLIANT THERAPEUTICS INC·Filed 2020·Granted Nov 5, 2024·0 cites·15 claims
- 2664US6861504B2Compounds and methods for the modulation of CD154CBR INC·Filed 2001·Granted Mar 1, 2005·3 cites·7 claims
- 2762US2024277807A1Actrii proteins and uses thereofACCELERON PHARMA INC·Filed 2022·Application pending·0 cites
- 2862US2023398181A1Treatments for complications associated with chronic liver diseaseACCELERON PHARMA INC·Filed 2023·Application pending·0 cites
- 2962US2023398182A1Treatments for hermansky-pudlak syndromeACCELERON PHARMA INC·Filed 2023·Application pending·0 cites
- 3060US2024277806A1Actrii proteins and uses thereofACCELERON PHARMA INC·Filed 2022·Application pending·0 cites
- 3160US2008254036A1Combination anticoagulant therapy with a compound that acts as a factor xa inhibitorMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 3259US2023174620A1Actrii proteins and use in treating post-capillary pulmonary hypertensionACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 3358US2005202007A1Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activityFiled 2004·Application pending·0 cites
- 3458US2024197902A1Actrii-alk4 antagonists and methods of treating heart failureACCELERON PHARMA INC·Filed 2022·Application pending·0 cites
- 3557US2008279845A1Combination therapy with a compound acting as a platelet adp receptor inhibitorPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3657US2009048216A1Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitorPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3757US2008193949A1Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activityBLOOD RES CENTER·Filed 2008·Application pending·0 cites
- 3856US2025064952A1Actrii-alk4 antagonists and methods of treating heart failureACCELERON PHARMA INC·Filed 2022·Application pending·0 cites
- 3956US2024181007A1Compositions and methods for treating pulmonary hypertensionACCELERON PHARMA INC·Filed 2022·Application pending·0 cites
- 4055US2009012136A1Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonistsPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 4155US2009012115A1Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populationsPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 4254US2013315897A1Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa InhibitorMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 4354US2012009172A1Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitorGRETLER DANIEL D·Filed 2011·Application pending·0 cites
- 4454US2024252628A1Actrii-alk4 antagonists and methods of treating heart failureACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 4551US2004048803A1Compounds and methods for the modulation of CD154Filed 2003·Application pending·0 cites
- 4648US2008209724A1Support tube for a cold-shrink sleeve for joining electric cablesNEXANS·Filed 2008·Application pending·0 cites
- 4747US8470357B2Methods of treatment with Syk inhibitorsANDRE PATRICK·Filed 2011·Granted Jun 25, 2013·0 cites·11 claims
- 4843US6496561B1Devices, methods and systems for delivery of X-rayMEDTRONIC AVE INC·Filed 1998·Granted Dec 17, 2002·37 cites·54 claims
- 4942US2007029792A1Support tube for a cold-shrink sleeve for joining electric cablesANDRE PATRICK·Filed 2006·Application pending·0 cites
- 5039US2002031508A1Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activityFiled 2001·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Patrick Andre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →